First Year of the Genetic Encyclopedia

In July 2019, Novel Software Systems launched the website
Genokarta Encyclopedia was created as a genetic encyclopedia with materials in user-friendly language, aimed at a Russian-speaking audience such as doctors, patients, researchers and students.
348 original articles on diseases, 373 articles on genes and 140 news were published during the first year of the project. More than 8 million pages were generated on mutations and variations.
The most readable articles are about diseases, as they make up 17 of the 20 most popular pages. Most popular pages about diseased are the following:

  • albinism,
  • double eyelash row,
  • Bruton’s disease,
  • lactose intolerance and
  • neurofibromatosis.

The most requested genes in the encyclopedia are:

  • COMT,
  • DRD2,
  • TP53,
  • MTRR and
  • BRAF.

The most commonly studied mutations and variations are:

  • RS1801133_GA,
  • RS4680_GA,
  • RS18011131_TG,
  • RS4988235_GA,
  • RS1799945_CG.

80% of the audience consists of visitors from Russia. 10% of audience is from Ukraine, Kazakhstan, Belarus, Uzbekistan and Moldova, and 10% more are from other places. The encyclopedia is also read by Russian-speaking audiences from the United States, Germany and Israel. In Russia, 36% of the audience is in Moscow, Moscow Region and Saint Petersburg.

The CEO of Novel Software Systems and the founder of the encyclopedia project, Dmitry Shtokalo, believes that the encyclopedia now satisfies about 10% of search queries about genetic diseases, and has a great potential for growth. He says "We plan to achieve three strategic goals:
1. Draw up a national map of the most prominent specialists and health centres specializing in the diagnosis of certain genetic diseases.
2. Establishment of training courses in medical genetics.
3. Create Russian Association of Bioinformatic IT Solutions Developers.
As a result, we see the creation of a powerful portal on the basis of the Genokarta that solves the information problems of medical genetics in Russia".